Humana Inc.
HUM
$251.02
-$2.33-0.92%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.78B | 28.03B | 28.28B | 28.44B | 28.55B |
| Total Other Revenue | 1.34B | 1.18B | 1.11B | 1.10B | 1.06B |
| Total Revenue | 32.11B | 29.21B | 29.40B | 29.54B | 29.61B |
| Cost of Revenue | 26.54B | 25.38B | 25.12B | 25.04B | 25.12B |
| Gross Profit | 5.58B | 3.83B | 4.28B | 4.50B | 4.49B |
| SG&A Expenses | 3.36B | 3.84B | 3.28B | 3.08B | 3.01B |
| Depreciation & Amortization | 183.00M | 208.00M | 210.00M | 212.00M | 209.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.07B | 29.43B | 28.61B | 28.33B | 28.35B |
| Operating Income | 2.04B | -213.00M | 783.00M | 1.21B | 1.27B |
| Income Before Tax | 1.65B | -899.00M | 635.00M | 901.00M | 990.00M |
| Income Tax Expenses | 406.00M | -216.00M | 155.00M | 223.00M | 251.00M |
| Earnings from Continuing Operations | 1.24B | -683.00M | 480.00M | 678.00M | 739.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -10.00M | -- | 1.00M | 2.00M |
| Net Income | 1.24B | -693.00M | 480.00M | 679.00M | 741.00M |
| EBIT | 2.04B | -213.00M | 783.00M | 1.21B | 1.27B |
| EBITDA | 2.25B | 27.00M | 1.03B | 1.45B | 1.51B |
| EPS Basic | 10.31 | -5.75 | 3.99 | 5.64 | 6.13 |
| Normalized Basic EPS | 8.68 | -3.04 | 3.58 | 5.04 | 5.28 |
| EPS Diluted | 10.30 | -5.76 | 3.98 | 5.63 | 6.11 |
| Normalized Diluted EPS | 8.66 | -3.04 | 3.57 | 5.03 | 5.27 |
| Average Basic Shares Outstanding | 120.67M | 120.46M | 120.41M | 120.45M | 120.98M |
| Average Diluted Shares Outstanding | 120.84M | 120.46M | 120.76M | 120.67M | 121.27M |
| Dividend Per Share | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 |
| Payout Ratio | 8.68% | -15.58% | 22.29% | 15.76% | 14.71% |